Eli Lilly
LLY
$5.68 (-0.51%)
1D
1W
3M
1Y
5Y
ALL
Eli Lilly and Company is a drug manufacturing company. The Company is engaged in the discovery, development, manufacturing, marketing, and sales of pharmaceutical products across the world. The Company's diabetes products include Baqsimi, Basaglar, Humalog, Humulin, Jardiance, Lyumjev, Trajenta and Trulicity. Its oncology products include Alimta, Cyramza, Erbitux, Retevmo, Tyvyt and Verzenio. The Company's immunology products consist of Olumiant and Taltz. Its neuroscience products include Cymbalta, Emgality, Reyvow and Zyprexa. Its other therapies consist of Bamlanivimab, etesevimab, Cialis and Forteo. The Company manufactures and distributes its products through facilities in the United States, including Puerto Rico, and about eight other countries. Its products are sold in approximately 120 countries. Its subsidiaries include Acanthas Pharma, Inc., Alnara Pharmaceuticals, Inc., ARMO Biosciences, Inc., and Avid Radiopharmaceuticals, Inc., among others.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Benzinga • 8 hours ago • LLY
How To Earn $500 A Month From Eli Lilly Stock Ahead Of Q2 Earnings
The Motley Fool • 9 hours ago • LLY
Eli Lilly Is Up 7% in 2026 and Has Major Catalysts on the Way. Is the Rally Just Getting Started?
Investopedia • 9 hours ago • LLY
Here's How Much Traders See Eli Lilly Stock Moving After Earnings
Reuters • 1 day ago • LLY
Eli Lilly to offer early access to next-gen obesity drug to some patients
The Motley Fool • 1 day ago • LLY
Is Eli Lilly Stock Running out of Steam?
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.